Welcome to Medications.com
Chi-Med Announces Start of Patient Enrolment in a Global Phase IIb ... - PharmaLive.com (press release)
In cell based assays, HMPL-004 has demonstrated its ability to inhibit TNF-alpha and IL-1 beta production and to inhibit NF-kB activation. ...
http://www.pharmalive.com/News/in... |
Posted: Fri Feb 29 08:33:16 -0500 2008
Beta Med RSS FeedFrequently Reported Side Effects of Beta Med
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
